FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Atellica IM Total PSA II (tPSAII)
K Number: K251630
·
Decision Jan 5, 2026
Classifications
1
FEI Numbers
32
Registration Numbers
32
Same Product Code
33
Applicant Total
152
Review Days
222
Basic Information
- Device Name
- Atellica IM Total PSA II (tPSAII)
- K Number
- K251630
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.6010
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Siemens Healthcare Diagnostics, Inc.
- Date Received
- May 28, 2025
- Decision Date
- January 5, 2026
- Product Code
- LTJ
- Advisory Committee
- Immunology
- Review Advisory Committee
- IM
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LTJ | Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (LTJ), ordered by most recent decision date.
FREND PSA PLUS (reagent cartridge)
FDA 510(k)
FDA Class 2
·Immunology
FREND PSA PLUS (REAGENT CARTRIDGE)
FDA 510(k)
FDA Class 2
·Immunology
TPSA FLEX REAGENT CARTRIDGE
FDA 510(k)
FDA Class 2
·Immunology
COMPLEXED PROSTATE SPECIFIC ANTIGEN (CPSA) ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM
FDA 510(k)
FDA Class 2
·Immunology
PROSTATE SPECIFIC ANTIGEN (PSA) ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM
FDA 510(k)
FDA Class 2
·Immunology
VIDAS TOTAL PROSTATE SPECIFIC ANTIGEN (TPSA), MODEL 30 428
FDA 510(k)
FDA Class 2
·Immunology
Other Clearances by Siemens Healthcare Diagnostics, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K251998 | Atellica CH Diazo Total Bilirubin (D_TBil) | Feb 27, 2026 | Substantially Equivalent |
| K251543 | Atellica® IM TSH3-Ultra II (TSH3ULII) | Feb 6, 2026 | Substantially Equivalent |
| K250816 | ADVIA Centaur Anti-Thyroglobulin II (aTgII) | Dec 4, 2025 | Substantially Equivalent |
| K250250 | ADVIA Centaur Anti-Thyroid Peroxidase II | Oct 17, 2025 | Substantially Equivalent |
| K242981 | Atellica IM Thyroglobulin (Tg) | Jun 20, 2025 | Substantially Equivalent |
| K242685 | Atellica® CH Creatinine_3 (Crea3) | Dec 4, 2024 | Substantially Equivalent |
| K241800 | Atellica® CH HDL Cholesterol (HDLC)& Atellica® CH LDL Cholesterol (LDLC) | Jul 26, 2024 | Substantially Equivalent |
| K241165 | Atellica® IM High-Sensitivity Troponin I (TnIH) | Jul 25, 2024 | Substantially Equivalent |
| K233050 | ADVIA Centaur® TSH3-Ultra II (TSH3ULII) | Apr 4, 2024 | Substantially Equivalent |
| K233242 | Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2) | Jan 18, 2024 | Substantially Equivalent |